Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May Han(Atara Biotherapeutics (United States)), Lawrence Steinman(Stanford University), Deborah H. Lundgren(UConn Health), Cedric S. Raine(Albert Einstein College of Medicine), Sun‐Il Hwang(UConn Health), Raymond A. Sobel(Stanford University), Guy Haskin Fernald(University of California, San Francisco), Shalina S. Ousman(Institute of Neurological Sciences), David K. Han(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Dolly Roy(Northridge Hospital Medical Center), Bruce Gerlitz(Eli Lilly (United States)), Brian W. Grinnell(Eli Lilly (United States)), Sergio E. Baranzini(University of California, San Francisco), Jordan V. Price(Institute of Neurological Sciences), William H. Robinson(VA Palo Alto Health Care System)
Cited by 519
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling
|Cell|1997|1.3k
Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis
|Journal of Biological Chemistry|2001|652
An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis
|Science Translational Medicine|2013|509